Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
Identifieur interne : 000B01 ( Ncbi/Checkpoint ); précédent : 000B00; suivant : 000B02Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
Auteurs : Steffen Nock [États-Unis]Source :
- IDrugs : the investigational drugs journal [ 1369-7056 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Anticorps monoclonaux, Conception de médicament, Humains, Industrie pharmaceutique, Internationalité, Médicaments en essais cliniques, Philadelphie, Recherche (tendances), Technologie pharmaceutique, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), Virus du SRAS (immunologie).
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical : Antibodies, Monoclonal, Drugs, Investigational.
- immunology : HIV-1, SARS Virus.
- trends : Research.
- Animals, Drug Design, Drug Industry, Humans, Internationality, Philadelphia, Technology, Pharmaceutical.
Abstract
Overall, the sessions were well attended and a lot of questions were asked. Two-thirds of the speakers were from industry and the rest from academia. Of particular note, The academics presented cutting-edge science in the antibody discovery and development area. Business representatives from various therapeutic antibody companies discussed in detail various aspects and challenges of building a viable therapeutic antibody company.
PubMed: 15470596
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B27
- to stream PubMed, to step Curation: 002B27
- to stream PubMed, to step Checkpoint: 002E28
- to stream Ncbi, to step Merge: 000B01
- to stream Ncbi, to step Curation: 000B01
Links to Exploration step
pubmed:15470596Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.</title>
<author><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name>
<affiliation wicri:level="2"><nlm:affiliation>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043, USA. snock@abslus.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15470596</idno>
<idno type="pmid">15470596</idno>
<idno type="wicri:Area/PubMed/Corpus">002B27</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B27</idno>
<idno type="wicri:Area/PubMed/Curation">002B27</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B27</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E28</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E28</idno>
<idno type="wicri:Area/Ncbi/Merge">000B01</idno>
<idno type="wicri:Area/Ncbi/Curation">000B01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B01</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.</title>
<author><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name>
<affiliation wicri:level="2"><nlm:affiliation>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043, USA. snock@abslus.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">IDrugs : the investigational drugs journal</title>
<idno type="ISSN">1369-7056</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Monoclonal</term>
<term>Drug Design</term>
<term>Drug Industry</term>
<term>Drugs, Investigational</term>
<term>HIV-1 (immunology)</term>
<term>Humans</term>
<term>Internationality</term>
<term>Philadelphia</term>
<term>Research (trends)</term>
<term>SARS Virus (immunology)</term>
<term>Technology, Pharmaceutical</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps monoclonaux</term>
<term>Conception de médicament</term>
<term>Humains</term>
<term>Industrie pharmaceutique</term>
<term>Internationalité</term>
<term>Médicaments en essais cliniques</term>
<term>Philadelphie</term>
<term>Recherche (tendances)</term>
<term>Technologie pharmaceutique</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Drugs, Investigational</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Recherche</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Research</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Drug Design</term>
<term>Drug Industry</term>
<term>Humans</term>
<term>Internationality</term>
<term>Philadelphia</term>
<term>Technology, Pharmaceutical</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Anticorps monoclonaux</term>
<term>Conception de médicament</term>
<term>Humains</term>
<term>Industrie pharmaceutique</term>
<term>Internationalité</term>
<term>Médicaments en essais cliniques</term>
<term>Philadelphie</term>
<term>Technologie pharmaceutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Overall, the sessions were well attended and a lot of questions were asked. Two-thirds of the speakers were from industry and the rest from academia. Of particular note, The academics presented cutting-edge science in the antibody discovery and development area. Business representatives from various therapeutic antibody companies discussed in detail various aspects and challenges of building a viable therapeutic antibody company.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B01 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000B01 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:15470596 |texte= Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:15470596" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |